Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia

Clinical Infectious Diseases

Volumn 27, Issue 2, 1998, Pages 296-302

  White, Mary H ^c   Bowden, Raleigh A ^d   Sandler, Eric S ^d   Graham, Michael L ^a   Noskin, Gary A ^d   Wingard, John R ^b   Goldman, Mitchell ^d   Van Burik, Jo Anne ^d   McCabe, Anne ^d   Lin, Jin Sying ^d   Gurwith, Marc ^d   Miller, Carole B ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; CYCLOSPORIN; TACROLIMUS;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUTROPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 7344264567     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514672     Document Type: Article

References (10)

1. Schimpff SC, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971;284:1061-5.
2. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72:101-11.
3. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86:668-72.
4. Allende MC, Lee JW, Francis P, et al. Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis. Antimicrob Agents Chemother 1994;38: 518-22.
5. Bowden RA, Cays M, Gooley T, Mamelok RD, van Burik J-A. Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant. J Infect Dis 1996;173: 1208-15.
6. White MH, Anaissie EJ, Kusne S, et al. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis 1997;24:635-42.
7. Denning DW, Lee JY, Hosteller JS, et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994;97:135-44.
8. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
9. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graftversus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304.
10. Walsh T, Bodensteiner D, Hiemenz J, et al. A randomized, double-blind trial of AmBisome (liposomal amphotericin B) in the empirical treatment of persistently febrile neutropenic patients [abstract LM-90]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.